Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 6/20 | 0.52 |
| ▸ | CA2 | P00918 | 6/20 | 0.52 |
| ▸ | CA9 | Q16790 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CTRC | Q99895 | 1/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14276077 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C9CYP2C19MEN1KMT2A | |
| SCHEMBL12771002 | 0.81 | POLB (0.40) | CYP1A2CYP2C9CYP2C19MEN1KMT2A | |
| SCHEMBL3669947 | 0.81 | AMY1A (0.65) | CYP1A2CYP2C9CYP2C19MEN1KMT2A | |
| SCHEMBL3669949 | 0.81 | AMY1A (0.65) | CYP1A2CYP2C9CYP2C19MEN1KMT2A | |
| SCHEMBL14276085 | 0.74 | GAA (0.48) | MEN1KMT2APOLBCA12CA2 | |
| SCHEMBL9465026 | 0.74 | CA12 (0.59) | CYP1A2CYP2C9CYP2C19MEN1KMT2A | |
| SCHEMBL29735007 | 0.73 | RAB9A (0.67) | MEN1KMT2APOLBCYP3A4CA12 | |
| SCHEMBL29368986 | 0.73 | RAB9A (0.67) | MEN1KMT2APOLBCYP3A4CA12 | |
| SCHEMBL5605340 | 0.73 | RAB9A (0.67) | MEN1KMT2APOLBCYP3A4CA12 | |
| SCHEMBL8025627 | 0.73 | RAB9A (0.67) | MEN1KMT2APOLBCYP3A4CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7056996-B2 | Productivity catalysts and microstructure control | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-06-06 | — | — | US | disclosed |
| US-20040127658-A1 | Productivity catalysts and microstructure control | EASTMAN CHEMICAL COMPANY | 2004-07-01 | — | — | US | disclosed |
| US-20040077809-A1 | Productivity catalysts and microstructure control | EASTMAN CHEMICAL COMPANY | 2004-04-22 | — | — | US | disclosed |
| US-20030225228-A1 | Catalysts containing N-pyrrolyl substituted nitrogen donors | EASTMAN CHEMICAL COMPANY | 2003-12-04 | — | — | US | disclosed |
| EP-1351997-A2 | IMPROVED PRODUCTIVITY CATALYSTS AND MICROSTRUCTURE CONTROL | EASTMAN CHEMICAL COMPANY (US) | 2003-10-15 | — | — | EP | disclosed |
| US-6605677-B2 | Group 8-10 transition metal based supported catalyst where the support is treated with a pore-filling agent; improved the catalyst productivity in the presence of hydrogen | EASTMAN CHEMICAL COMPANY | 2003-08-12 | — | — | US | disclosed |
| US-6545108-B1 | Ti, Zr, Hf, Cr, Mo, W, V, Nb, or Ta complex of a monodentate dianionic ligand in which a nitrogen atom is substituted by a 1-pyrrolyl and the remaining donor atoms are N, P, As, O, S, or Se | EASTMAN CHEMICAL COMPANY | 2003-04-08 | — | — | US | disclosed |
| EP-1278784-A2 | CATALYSTS CONTAINING N-PYRROLYL SUBSTITUTED NITROGEN DONORS | EASTMAN CHEMICAL COMPANY (US) | 2003-01-29 | — | — | EP | disclosed |
| US-20020091210-A1 | Olefin polymerization processes using supported catalysts | E. I. DU PONT DE NEMOURS AND COMPANY | 2002-07-11 | — | — | US | disclosed |
| US-20020065192-A1 | Productivity catalysts and microstructure control | MACKENZIE PETER BORDEN (US) | 2002-05-30 | — | — | US | disclosed |
| WO-2002036641-A2 | IMPROVED PRODUCTIVITY CATALYSTS AND MICROSTRUCTURE CONTROL | EASTMAN CHEMICAL COMPANY (US) | 2002-05-10 | — | — | WO | disclosed |
| WO-2001083571-A2 | CATALYSTS CONTAINING N-PYRROLYL SUBSTITUTED NITROGEN DONORS | EASTMAN CHEMICAL COMPANY (US) | 2001-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077809-A1 | Productivity catalysts and microstructure control | MYB, ST3GAL3, FASN | CYP1A2 932/4885CYP2C9 3754/4885CYP2C19 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.